These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6831407)

  • 21. Response of tumor and host to hyperalimentation and antiglutamine treatments.
    Chance WT; Cao LQ; Fischer JE
    JPEN J Parenter Enteral Nutr; 1990; 14(2):122-8. PubMed ID: 2112618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of cell cycle progression of human pancreatic carcinoma cells in vitro by L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, Acivicin (NSC 163501).
    Meck RA; Clubb KJ; Allen LM; Yunis AA
    Cancer Res; 1981 Nov; 41(11 Pt 1):4547-53. PubMed ID: 7306976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of calmodulin antagonist berbaminederivative-EBB on hepatoma in vitro and in vivo.
    Liu J; Qi S; Zhu H; Zhang J; Li Z; Wang T
    Chin Med J (Engl); 2002 May; 115(5):759-62. PubMed ID: 12133551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenosine and tubercidin binding and transport in Chinese hamster ovary and Novikoff rat hepatoma cells.
    Plagemann PG; Wohlhueter RM
    J Cell Physiol; 1983 Aug; 116(2):247-55. PubMed ID: 6863404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo inactivation of formylglycinamidine ribonucleotide synthetase in rat hepatoma.
    Elliott WL; Weber G
    Biochem Pharmacol; 1985 Jan; 34(2):243-8. PubMed ID: 3966925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleosides and nucleotides. 180. Synthesis and antitumor activity of nucleosides that have a hydroxylamino group instead of a hydroxyl group at the 2'- or 3'-position of the sugar moiety.
    Ogawa A; Tanaka M; Sasaki T; Matsuda A
    J Med Chem; 1998 Dec; 41(25):5094-107. PubMed ID: 9836625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acivicin reduces tumor growth during total parenteral nutrition (TPN).
    Chance WT; Cao L; Nelson JL; Foley-Nelson T; Fischer JE
    Surgery; 1987 Aug; 102(2):386-94. PubMed ID: 3112985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged survival by tumor-bearing rats treated with acivicin and total parenteral nutrition.
    Chance WT; Cao LQ; Fischer JE
    J Natl Cancer Inst; 1990 Mar; 82(5):432-4. PubMed ID: 2106035
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevention of thymidine and hypoxanthine rescue from MTA (LY231514) growth inhibition by dipyridamole in human lung cancer cell lines.
    Smith PG; Marshman E; Calvert AH; Newell DR; Curtin NJ
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):63-7. PubMed ID: 10598557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acivicin in 1985.
    Earhart RH; Neil GL
    Adv Enzyme Regul; 1985; 24():179-205. PubMed ID: 3915184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid in vivo inactivation by acivicin of CTP synthetase, carbamoyl-phosphate synthetase II, and amidophosphoribosyltransferase in hepatoma.
    Denton JE; Lui MS; Aoki T; Sebolt J; Weber G
    Life Sci; 1982 Mar; 30(13):1073-80. PubMed ID: 7078346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein binding.
    Curtin NJ; Bowman KJ; Turner RN; Huang B; Loughlin PJ; Calvert AH; Golding BT; Griffin RJ; Newell DR
    Br J Cancer; 1999 Aug; 80(11):1738-46. PubMed ID: 10468290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic channeling of 5-fluoro-2'-deoxycytidine utilizing inhibitors of its deamination in cell culture.
    Boothman DA; Briggle TV; Greer S
    Mol Pharmacol; 1985 May; 27(5):584-94. PubMed ID: 2581125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurin.
    Prajda N; Natsumeda Y; Ikegami T; Reardon MA; Szondy S; Hashimoto Y; Emrani J; Weber G
    Biochem Pharmacol; 1988 Mar; 37(5):875-80. PubMed ID: 3345200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzyme targets of antiglutamine agents in cancer chemotherapy.
    Prajda N
    Adv Enzyme Regul; 1985; 24():207-23. PubMed ID: 2424283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiproliferative effects of N1,N4-dibenzylputrescine in human and rodent tumor cells.
    Aizencang G; Harari P; Buldain G; Guerra L; Pickart M; Hernandez P; Frydman B
    Cell Mol Biol (Noisy-le-grand); 1998 Jun; 44(4):615-25. PubMed ID: 9678897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dipyridamole inhibits reversion by thymidine of methotrexate effect and increases drug uptake in Sarcoma 180 cells.
    Cabral S; Leis S; Bover L; Nembrot M; Mordoh J
    Proc Natl Acad Sci U S A; 1984 May; 81(10):3200-3. PubMed ID: 6587345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of antitumor activity of glutamine antagonists 6-diazo-5-oxo-L-norleucine and acivicin in cell culture by glutaminase-asparaginase.
    Rosenfeld H; Roberts J
    Cancer Res; 1981 Apr; 41(4):1324-8. PubMed ID: 7214322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acivicin inhibits Crithidia fasciculata growth in a serum-free medium and inactivates carbamoyl-phosphate synthetase II in vivo.
    Aoki T; Oya H
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988; 90(2):391-6. PubMed ID: 2902999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of HL-60 cells by dimethylsulfoxide activates a Na(+)-dependent nucleoside transport system.
    Lee CW; Sokoloski JA; Sartorelli AC; Handschumacher RE
    In Vivo; 1994; 8(5):795-801. PubMed ID: 7727727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.